Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )

NCT04443322 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Liver Carcinoma
Liver Transplant; Complications

Interventions

DRUG: Durvalumab Injection
DRUG: Lenvatinib 4 MG

Sponsor

RenJi Hospital